Comparison of the benefit of primary prevention implantable cardioverter-defibrillator therapy in ischemic versus nonischemic dilated cardiomyopathy
Kun Wang, MD1#; Xinyue Xu, MD1#; Yu Qi, PhD1#; Yihai Liu, PhD2; Lina Kang, MD1; Xiaohong Li, MD1; Rongfang Lan, MD1; Lian Wang, MD1*; Wei Xu, MD1*
# These authors contributed equally.
1)Department of Cardiology, Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China.
2)Department of Cardiology, Nanjing Drum Tower Hospital, Clinical College of Nanjing Medical University, Nanjing 210008, China.
This work was supported by grants from the Key Projects of Science and Technology Development Foundation of Nanjing Department of Health (201704003 to L. Wang) and the Six Talent Peaks Project in Jiangsu Province (2016-WSN-157 to L. Wang).